We observed a trend of lower plasma MMP1 levels with increasing tumour size (Odds ratio OR 1.11, p = 0.07) and found significantly lower MMP1 expression in patients with inflammatory breast cancer (OR 0.74, p = 0.02, Figure 2a). The gene discussed is MMP1; the disease is inflammatory breast carcinoma.